Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,895 | 0,965 | 13:54 | |
0,895 | 0,960 | 13:54 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
24.09. | GRAND PHARMA (00512): INTERIM REPORT 2025 | - | HKEx | ||
24.09. | GRAND PHARMA (00512): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | - | HKEx | ||
24.09. | GRAND PHARMA (00512): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | - | HKEx | ||
23.09. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: TREPROSTINIL INJECTION (20ML: 50MG) IS GRANTED A DRUG REGISTRATION CERTIFICATE | 3 | HKEx | ||
GRAND PHARMACEUTICAL GROUP Aktie jetzt für 0€ handeln | |||||
08.09. | Sirtex Medical Inc.: Sirtex Receives Expanded CE Mark Approval for SIR-Spheres Y-90 Resin Microspheres | 253 | PR Newswire | Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories.
WOBURN, Mass., Sept. 8, 2025 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading... ► Artikel lesen | |
08.09. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: NEW INDICATION OF THE GROUP'S GLOBALLY INNOVATIVE RADIOACTIVE PRODUCT SIR-SPHERES Y-90 RESIN MICROSPHERE ... | 2 | HKEx | ||
27.08. | GRAND PHARMA (00512): CONTINUING CONNECTED TRANSACTION | - | HKEx | ||
19.08. | GRAND PHARMA (00512): 2025 INTERIM RESULTS ANNOUNCEMENT | - | HKEx | ||
05.08. | GRAND PHARMA (00512): DATE OF BOARD MEETING | 1 | HKEx | ||
28.07. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: RESTRUCTURING OF THE SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER GROUP | 2 | HKEx | ||
22.07. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE APPLICATION FOR THE GROUP'S GLOBAL INNOVATIVE RDC TLX591 TO JOIN AN INTERNATIONAL MULTICENTER PHASE ... | 1 | HKEx | ||
17.07. | GRAND PHARMA (00512): SUPPLEMENTAL ANNOUNCEMENT TO CONTINUING CONNECTED TRANSACTIONS: BUSINESS COLLABORATION AGREEMENT | 1 | HKEx | ||
17.07. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE WORLD'S FIRST NASAL SPRAY PRODUCT OF THE GROUP FOR THE TREATMENT OF DRY EYE DISEASE, OC-01, ACHIEVES ... | 2 | HKEx | ||
07.07. | SIR-Spheres® Y-90 Harz-Mikrosphären von Sirtex Medical erhalten FDA-Zulassung für die Behandlung des inoperablen Leberzellkarzinoms | 379 | news aktuell | Woburn, Massachusetts (ots/PRNewswire) - Erweiterte Indikation macht SIR-Spheres® zur ersten und einzigen Radioembolisationstherapie in den USA, die sowohl zur Behandlung des inoperablen Leberzellkarzinoms... ► Artikel lesen | |
07.07. | Sirtex Medical Inc.: Sirtex Medical's SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma | 252 | PR Newswire | Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer
WOBURN... ► Artikel lesen | |
07.07. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: A NEW INDICATION OF THE GROUP'S GLOBALLY INNOVATIVE RADIOACTIVE PRODUCT SIR-SPHERES Y-90 RESIN MICROSPHERE ... | 2 | HKEx | ||
04.06. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE GROUP'S GLOBAL INNOVATIVE OPHTHALMIC DRUG CBT-001 COMPLETES THE ENROLLMENT OF ALL PATIENTS IN THE INTERNATIONAL ... | 3 | HKEx | ||
12.05. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE PHASE III STUDY IN CHINA OF THE GROUP'S GLOBAL INNOVATIVE RDC TLX591-CDX COMPLETES PATIENT ENROLLMENT ... | 2 | HKEx | ||
07.05. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE APPLICATION FOR THE GROUP'S GLOBAL INNOVATIVE RDC TLX591 TO JOIN INTERNATIONAL MULTICENTER PHASE III ... | - | HKEx | ||
07.05. | Grand Pharmaceutical Group Limited: The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China | 426 | PR Newswire | The results showed that the SOFA scores of the drug treatment groups on the 7th day were significantly lower than those of the baseline, especially in the high-dose group, where the decrease... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 46,900 | +1,41 % | Fresenius Medical Care: War das die Trendwende? | ||
CARL ZEISS MEDITEC | 44,560 | -1,15 % | Carl Zeiss Meditec AG: ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization | Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography... ► Artikel lesen | |
ECKERT & ZIEGLER | 17,585 | +0,09 % | Eckert & Ziegler mit SONDERMELDUNG: Könnte die Aktie jetzt komplett drehen - Profis haben bereits gehandelt! | ||
MEDTRONIC | 84,57 | +0,21 % | Medtronic begins U.S. clinical study of Hugo robot for gynecological surgery | ||
SERNOVA BIOTHERAPEUTICS | 0,116 | -0,85 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
FAMICORD | 5,850 | +1,74 % | EQS-Adhoc: FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. erwirbt 100 % der Anteile an der Stammzellbank 'nOvum' spólka z ograniczona odpowiedzialnoscia, Warschau, Polen | EQS-Ad-hoc: FamiCord AG / Schlagwort(e): Fusionen & Übernahmen
FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. erwirbt 100 % der Anteile an der Stammzellbank 'nOvum' spólka z ograniczona... ► Artikel lesen | |
GERATHERM MEDICAL | 5,700 | -2,73 % | Geratherm Medical AG: Starkes Wachstum im ersten Halbjahr und operatives Break-even; KAUFEN bestätigt. | Geratherm verzeichnete im ersten Halbjahr 2025 ein starkes Wachstum: Die vergleichbaren Umsätze stiegen um 13,2 % gegenüber dem Vorjahr und sequenziell um 15,4 %. Getrieben wurde dieses Wachstum von... ► Artikel lesen | |
PLUS THERAPEUTICS | 0,820 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide Cerebrospinal Fluid Assay for Metastatic CNS Cancer | HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), announced today that it has signed... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 48,480 | +0,33 % | Siemens Healthineers AG: Q4 2025 und GJ 2026 voraussichtlich von Gegenwind belastet. KAUFEN. | Die Siemens Healthineers AG (SHL) hat ihr Geschäftsjahr 2025 gestern beendet. Rückblickend lieferte SHL ein solides 9M FY25 (+6,4 % yoy, berichtete EBIT-Marge 13,3 %) und erhöhte die Prognose auf 5... ► Artikel lesen | |
FRESENIUS | 47,120 | +1,75 % | Fresenius SE - Range im Fokus | ||
GERRESHEIMER | 37,660 | +1,29 % | Almonty Industries, Gerresheimer, BASF - Noch ist es nicht zu spät! | Der Wettlauf um wichtige Güter aus der Hightechindustrie und um Rohstoffe hat längst begonnen. Die Corona Pandemie hat uns schmerzlich vor Augen geführt, was die Nachteile einer global vernetzten Wirtschaft... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 28,430 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
UNITEDHEALTH | 316,90 | +1,44 % | 3 Charts in 3x33 Sekunden - Heute mit NVIDIA, UnitedHealth Group und Palladium | Willkommen zu '3 Charts in 33 Sekunden'! Jörg Scherer stellt uns drei Charts vor, die er aktuell ganz besonders unter die Lupe nimmt. Welche Ziele oder Signale jetzt wichtig sind, erfahren Sie im Video!... ► Artikel lesen | |
ENVOY MEDICAL | 1,600 | 0,00 % | Envoy Medical, Inc.: Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | White Bear Lake, Minnesota--(Newsfile Corp. - October 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing... ► Artikel lesen | |
CLEARPOINT NEURO | 26,400 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen |